Infection Control Market by Product and End-user - Global Forecast to 2027 - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Infection Control Market by Product [Sterilization (Steam, Radiation, Sterilant, Indicators), Disinfection (Washer, UV Disinfection, Disinfectants), Endoscope Reprocessing, Protective Barriers], and End User - Global Forecast to 2027" report has been added to ResearchAndMarkets.com's offering.

The infection control market study presents historical market data in terms of value (2018, and 2019), estimated current data (2020), and forecasts for 2027 - by product, and end user. The study also evaluates industry competitors and analyzes the market at regional and country level.

On the basis of product type, the cleaning & disinfection products segment is estimated to account for the largest share of the overall infection control market in 2020. However, the endoscope reprocessing products segment is expected to grow at the fastest growth rate during the forecast year due to the growing importance of diagnostic and therapeutic endoscopy procedures, concerns regarding surgical wound-associated infections, and technological advancement in the medical field.

On the basis of end user, the hospitals & clinics segment is estimated to command the largest share of the overall infection control market in 2020. The large share of this segment is mainly attributed to the growing incidence of hospital acquired infections (HAIs) and rising number of surgical procedures. Apart from these factors, the increasing chronic diseases associated with aging population, growing awareness among people for quality care, rising number of hospitalization due to sudden outbreak of COVID-19, and focus on reducing the healthcare burden caused due to HAIs supported the dominance of this segment.

An in-depth analysis of the geographical scenario of the infection control market provides detailed qualitative and quantitative insights about the five major geographies (North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa) along with the coverage of major countries in each region. North America is estimated to dominate the overall infection control market in 2020, followed by Europe, and Asia Pacific. However, Asia Pacific region is expected to grow at the fastest CAGR during the forecast period, which is mainly attributed to the factors such as accelerated economic growth of many countries, growing government focus on healthcare sector, rising prevalence of infectious diseases including COVID-19, and government initiatives for boosting production of infection control products.

Market Dynamics

Drivers

• Incidence of Hospital-Acquired Infections
• Rising Number of Surgical Procedures
• Increasing Incidence of Chronic Diseases Associated with Growing Geriatric Population
• Impact of COVID-19 Pandemic on Infection Control Market
• Growing Medical Device Reprocessing Industry

Restraint

• Concerns Regarding the Safety of Reprocessed Instruments

Opportunities

• Growing Medical Device and Pharmaceutical Industries in Emerging Economies
• Increasing Use of E-Beam Sterilization
• Rising Importance of Single-Use Medical Protective Barriers

Challenge

• Noncompliance with Sterilization Standards in Medical Sector

Companies Mentioned

• 3M (U.S.)
• ACTO GmbH (Germany)
• ARC Healthcare Solutions Inc. (Canada)
• Advanced Sterilization Products (U.S.)
• Alpha-Cure Ltd (U.K.)
• Amray Radiation Protection (Ireland)
• Ansell (U.S.)
• BODE Chemie GmbH (Germany)
• Belimed (Switzerland)
• BiOZEEN (India)
• Biotrol (U.S.)
• Cantel Medical Corp. (U.S.)
• Certol International LLC. (U.S.)
• DORSAN (Spain)
• Dr. Schumacher GmbH (Germany)
• Dr. Schumacher GmbH (Germany)
• Ecolab (U.S.)
• Getinge AB (Sweden)
• Guardian (England)
• Hu-Friedy Mfg. Co. LLC (U.S.)
• IREMA (Ireland)
• Kilang MEDICOS (Malaysia)
• LIT Company (The Netherlands)
• Lumalier (U.S.)
• MATACHANA Group (Spain)
• MELAG Medizintechnik GmbH & Co. KG (Germany)
• MMM Group (Germany)
• Medisept (Poland)
• Medline International Two Australia Pty Ltd (Australia)
• Merck KGaA (Germany)
• Metrex Research LLC. (U.S.)
• NEX MEDICAL ANTISEPTICS Srl (Italy)
• PMS TbbiCihazlarTeknolojisi San. ve Tic. A.. (Turkey)
• PSK Pharma Pvt.Ltd (India)
• Pall Corporation (U.S.)
• STERIS plc. (U.S.)
• Shandong Delta-Medi Co. Ltd. (China)
• Shandong Delta-Medi Co. Ltd. (China)
• SharperTek (U.S.)
• Spire Integrated Solutions (U.S.)
• Steelco S.p.A. (Italy)
• Tronex International Inc. (U.S.)
• Tru-D SmartUVC (U.S.)
• Ultrawave (U.K.)
• Wassenburg Medical B.V. (Netherlands)
• Whiteley Corporation (Australia)
• XENEX Disinfection Systems (U.S.)
• priMED Medical Products Inc. (Canada)
  

For more information about this report visit https://www.researchandmarkets.com/r/1qld80